S

Swedencare AB (publ)
STO:SECARE

Watchlist Manager
Swedencare AB (publ)
STO:SECARE
Watchlist
Price: 46.28 SEK 2.16% Market Closed
Market Cap: 7.3B SEK
Have any thoughts about
Swedencare AB (publ)?
Write Note
Section:
 

Relative Value

The Relative Value of one SECARE stock under the Base Case scenario is 97.08 SEK. Compared to the current market price of 46.28 SEK, Swedencare AB (publ) is Undervalued by 52%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SECARE Relative Value
Base Case
97.08 SEK
Undervaluation 52%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

3
P/S
P/S
Price to Sales
3
vs History
73
vs Industry
35
Median 3Y
3.8
Median 5Y
4.2
Industry
2.5
Forward
2.8
More Details
96.4
P/E
P/E
Price to Earnings
96.4
vs History
58
vs Industry
3
Median 3Y
143.4
Median 5Y
131.4
Industry
21.9
Forward
51.9
More Details
17.7
P/OCF
P/OCF
Price to OCF
17.7
vs History
73
vs Industry
22
Median 3Y
22.1
Median 5Y
37.1
Industry
16.5
More Details
27.4
P/FCFE
P/FCFE
Price to FCFE
27.4
vs History
39
vs Industry
17
Median 3Y
15.3
Median 5Y
24.7
Industry
23.6
More Details
1
P/B
P/B
Price to Book Value
1
vs History
69
vs Industry
59
Median 3Y
1.2
Median 5Y
1.9
Industry
2.1
More Details
3.5
EV/S
EV/S
Enterprise Value to Sales
3.5
vs History
76
vs Industry
29
Median 3Y
4.4
Median 5Y
5
Industry
2.6
Forward
3.4
More Details
6.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.2
vs History
77
vs Industry
29
Median 3Y
8
Median 5Y
9.6
Industry
5.2
More Details
16.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
16.2
vs History
77
vs Industry
19
Median 3Y
21.8
Median 5Y
28.2
Industry
13.3
Forward
15.1
More Details
38.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
38.9
vs History
77
vs Industry
8
Median 3Y
64.7
Median 5Y
68.9
Industry
16.6
Forward
22.7
More Details
21.1
EV/OCF
EV/OCF
Enterprise Value to OCF
21.1
vs History
76
vs Industry
20
Median 3Y
26
Median 5Y
46.5
Industry
15.6
More Details
24.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
24.9
vs History
74
vs Industry
18
Median 3Y
30.6
Median 5Y
61.8
Industry
19.1
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
73
vs Industry
57
Median 3Y
1.1
Median 5Y
1.8
Industry
1.9
More Details

Multiples Across Competitors

SECARE Competitors Multiples
Swedencare AB (publ) Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Swedencare AB (publ)
STO:SECARE
7.3B SEK 3 96.4 16.2 38.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
SE
S
Swedencare AB (publ)
STO:SECARE
Average P/E: 40.4
96.4
512%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Summary
SECARE intrinsic value, competitors valuation, and company profile.
DCF Valuation
SECARE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SECARE stock valuation using valuation multiples.
Wall Street Estimates
SECARE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SECARE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 201,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.